The Indian pharmaceutical landscape presents a complex picture, increasingly characterized by concerns surrounding hegemonic practices. While the country is lauded as a global medicinal powerhouse and a crucial provider of affordable medicines, a growing number of experts are highlighting the tendency for a few large firms to control significant ma

India's pharmaceutical/drug/medicinal industry is a complex/dynamic/booming landscape. While it provides affordable/accessible/cheap medication to millions, concerns about monopoly/market dominance/oligopoly power held by certain firms/corporations/companies are growing/increasing/emerging. This situation/issue/concern raises/presents/highlights qu